These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26394701)

  • 1. Emerging circulating biomarkers in glioblastoma: promises and challenges.
    Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
    Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of glioblastoma in biofluids.
    Figueroa JM; Carter BS
    J Neurosurg; 2018 Aug; 129(2):334-340. PubMed ID: 29053069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Biomarkers for Prediction of Treatment Response.
    Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Circulating Biomarkers of Brain Tumors.
    Jelski W; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating biomarkers in patients with glioblastoma.
    Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
    Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients.
    Osti D; Del Bene M; Rappa G; Santos M; Matafora V; Richichi C; Faletti S; Beznoussenko GV; Mironov A; Bachi A; Fornasari L; Bongetta D; Gaetani P; DiMeco F; Lorico A; Pelicci G
    Clin Cancer Res; 2019 Jan; 25(1):266-276. PubMed ID: 30287549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
    Swellam M; Ezz El Arab L; Al-Posttany AS; B Said S
    J Neurooncol; 2019 Sep; 144(3):545-551. PubMed ID: 31422498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small extracellular vesicles as tumor biomarkers for glioblastoma.
    Mahmoudi K; Ezrin A; Hadjipanayis C
    Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.
    Chen Y; Jin Y; Wu N
    Cells; 2021 Feb; 10(3):. PubMed ID: 33670924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of liquid biopsy in glioblastoma - A review.
    Klekner Á; Szivos L; Virga J; Árkosy P; Bognár L; Birkó Z; Nagy B
    J Biotechnol; 2019 Jun; 298():82-87. PubMed ID: 30986516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme.
    Bennett IE; Guo H; Kountouri N; D'abaco GM; Hovens CM; Moffat BA; Desmond P; Drummond K; Kaye AH; Morokoff AP
    J Clin Neurosci; 2015 Nov; 22(11):1802-8. PubMed ID: 26308396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
    Gingras I; Salgado R; Ignatiadis M
    Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating biomarkers for gliomas.
    Westphal M; Lamszus K
    Nat Rev Neurol; 2015 Oct; 11(10):556-66. PubMed ID: 26369507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Biomarkers for Glioma: A Review.
    Jones J; Nguyen H; Drummond K; Morokoff A
    Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model.
    Greco F; Anastasi F; Pardini LF; Dilillo M; Vannini E; Baroncelli L; Caleo M; McDonnell LA
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.